Toggle menu

LAVAS

Start date:
Historic
End date:
June 2014
Co-ordinated by:
NHS Lothian

Lactate, Arterial and Venous Agreement in Sepsis – LAVAS trial

Aim

To determine whether an agreement between peripheral venous and arterial lactate exists in patients presenting to an Emergency Department with sepsis.

Trial Design

A prospective observational study in a consecutive sample of eligible and consented patients in the Royal Infirmary of Edinburgh

Eligibility criteria (summary)

Patients who present to the Emergency Department with suspected sepsis

Chief Investigator

Dr Deepankar Datta

Specialist Trainee Emergency Medicine

Local PI

Dr Deepankar Datta

Specialist Trainee Emergency Medicine

Research Team

Julia Grahamslaw

Lead Research Nurse

More EMERGE Trials

Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST 2)

Read more

ATTEST2

Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST 2)

This is a study looking at incidence and risk factors for poor ankle functional recovery, and the development and progression of post-traumatic ankle osteoarthritis after significant ankle ligament injury.

Read more

SALI Study

SALI study - Significant Ankle Ligament Injury

Strokes caused by a clot are described as ischaemic. When patients experience ischaemic strokes they may be eligible for “clot busting” therapy (thrombolysis). Currently thrombolysis has been shown to improve patient outcome after a stroke if administered within the first 4.5 hours after stroke onset. Up to 25% of patients wake up with symptoms of a stroke. This means they have an unknown onset time for their stroke (so called ‘wake up strokes’). With no known onset time, they are ineligible for thrombolysis. This study will investigate how we might determine stroke onset time.

Read more

MRI in Acute Stroke